ANAVEX LIFE SCIENCES CORP. Other Nonoperating Gains (Losses)
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Other Nonoperating Gains (Losses) of -$2.72 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-14.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingGainsLosses · last filed 2015-08-14
- ANAVEX LIFE SCIENCES CORP. other nonoperating gains (losses) for the quarter ending 2015-06-30 was -$2.72M, a 50222.51% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. other nonoperating gains (losses) for the quarter ending 2015-03-31 was -$912.36K.
- ANAVEX LIFE SCIENCES CORP. other nonoperating gains (losses) for the quarter ending 2014-12-31 was $37.65K, a 94.49% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. other nonoperating gains (losses) for the quarter ending 2014-09-30 was -$9.31M.
- ANAVEX LIFE SCIENCES CORP. other nonoperating gains (losses) for fiscal 2014 was -$8.62M.
- ANAVEX LIFE SCIENCES CORP. other nonoperating gains (losses) for fiscal 2013 was -$480.33K.
| Period end | Other Nonoperating Gains (Losses) 3 month | Other Nonoperating Gains (Losses) 6 month | Other Nonoperating Gains (Losses) 9 month | Other Nonoperating Gains (Losses) 12 month |
|---|---|---|---|---|
| 2015-06-30 | -$2.72M 10-Q · filed 2015-08-14 | -$3.63M derived: sum of 2 quarters · filed 2015-08-14 | -$3.59M 10-Q · filed 2015-08-14 | -$12.90M derived: sum of 4 quarters · filed 2015-08-14 |
| 2015-03-31 | -$912.36K 10-Q · filed 2015-05-14 | -$874.71K 10-Q · filed 2015-05-14 | -$10.19M derived: sum of 3 quarters · filed 2015-05-14 | -$10.18M derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-12-31 | $37.65K 10-Q · filed 2015-02-17 | -$9.27M derived: sum of 2 quarters · filed 2015-02-17 | -$9.27M derived: sum of 3 quarters · filed 2015-08-14 | -$9.27M derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-09-30 | -$9.31M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | -$9.31M derived: sum of 2 quarters · filed 2015-08-14 | -$9.31M derived: sum of 3 quarters · filed 2015-08-14 | -$8.62M 10-K · filed 2014-12-29 |
| 2014-06-30 | $5.42K 10-Q · filed 2015-08-14 | $4.41K derived: sum of 2 quarters · filed 2015-08-14 | $687.41K 10-Q · filed 2015-08-14 | |
| 2014-03-31 | -$1.01K 10-Q · filed 2015-05-14 | $681.99K 10-Q · filed 2015-05-14 | ||
| 2013-12-31 | $683.00K 10-Q · filed 2015-02-17 | |||
| 2013-09-30 | -$480.33K 10-K · filed 2014-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |